Neogen Valuation
| NEOG Stock | USD 5.67 0.31 5.78% |
At this time, the firm appears to be fairly valued. Neogen secures a last-minute Real Value of $5.6 per share. The latest price of the firm is $5.67. Our model forecasts the value of Neogen from analyzing the firm fundamentals such as Current Valuation of 2 B, return on equity of -0.42, and Profit Margin of (1.22) % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Neogen's price fluctuation is slightly risky at this time. Calculation of the real value of Neogen is based on 3 months time horizon. Increasing Neogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Neogen stock is determined by what a typical buyer is willing to pay for full or partial control of Neogen. Since Neogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Neogen Stock. However, Neogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.67 | Real 5.6 | Hype 5.58 | Naive 5.88 |
The real value of Neogen Stock, also known as its intrinsic value, is the underlying worth of Neogen Company, which is reflected in its stock price. It is based on Neogen's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Neogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Neogen helps investors to forecast how Neogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Neogen more accurately as focusing exclusively on Neogen's fundamentals will not take into account other important factors: Neogen Total Value Analysis
Neogen is now estimated to have valuation of 2 B with market capitalization of 1.23 B, debt of 894.11 M, and cash on hands of 347.71 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Neogen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2 B | 1.23 B | 894.11 M | 347.71 M |
Neogen Investor Information
About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.59. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Neogen has Price/Earnings To Growth (PEG) ratio of 0.66. The entity recorded a loss per share of 5.03. The firm had not issued any dividends in recent years. Neogen had 2:1 split on the 7th of June 2021. Based on the analysis of Neogen's profitability, liquidity, and operating efficiency, Neogen is not in a good financial situation at this time. It has a very high probability of going through financial hardship in October.Neogen Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Neogen implies not a very effective usage of assets in September.Neogen Ownership Allocation
The majority of Neogen outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Neogen to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Neogen. Please pay attention to any change in the institutional holdings of Neogen as this could imply that something significant has changed or is about to change at the company.Neogen Profitability Analysis
The company reported the previous year's revenue of 894.66 M. Net Loss for the year was (1.09 B) with profit before overhead, payroll, taxes, and interest of 421.38 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Neogen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Neogen and how it compares across the competition.
About Neogen Valuation
The stock valuation mechanism determines Neogen's current worth on a weekly basis. Our valuation model uses a comparative analysis of Neogen. We calculate exposure to Neogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Neogen's related companies.Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. Neogen Cp operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 2108 people.
Neogen Growth Indicators
Investing in growth stocks can be very risky. If the company such as Neogen does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 216.9 M | |
| Quarterly Earnings Growth Y O Y | -0.856 | |
| Forward Price Earnings | 16 |
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |